Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Tekmira's Shorter Path To Profitability
Seeking Alpha
Friday, January 17, 2014 - 9:16am
tags:
Tekmira Pharmaceuticals, drug delivery, nucleic acid delivery
Spotlight 2014-Biotech CytRx Corporation
Seeking Alpha
Friday, January 17, 2014 - 9:14am
tags:
CytRx, aldoxorubicin
Gentium shareholders cry foul on $1B Jazz deal
Fierce Biotech
Friday, January 17, 2014 - 9:05am
tags:
Gentium, Jazz Pharmaceuticals, M&A
Renal denervation is 'highly unlikely,' says Medtronic study insider
Mass Device
Friday, January 17, 2014 - 9:01am
tags:
Medtronic, renal denervation
Pharma Critics Want Complete Clinical Trial Transparency, Yet Want To Ban Publishing Pharma Funded Studies
Forbes
Friday, January 17, 2014 - 8:46am
tags:
clinical trials, transparency, R&D
Look for Teva's new chief to move fast on dealmaking, CFO says
Fierce Pharma
Friday, January 17, 2014 - 8:44am
tags:
Teva, M&A, Erez Vigodman
Roche resolves shortage of liquid Tamiflu
Fierce Pharma
Friday, January 17, 2014 - 8:43am
tags:
Roche, Tamiflu, drug shortages, Flu
Shire takes $650 mln hit on Dermagraft sale
Reuters
Friday, January 17, 2014 - 8:41am
tags:
Dermagraft, Shire, Organogenesis
J&J Continues ‘Strategic Pruning’ With This Divestiture
Wall St Cheat Sheet
Friday, January 17, 2014 - 8:40am
tags:
JNJ, diagnostics, Ortho Clinical Diagnostics, Carlyle
ArQule shares rise after committee say liver cancer study can continue with lower drug dose
Yahoo/AP
Friday, January 17, 2014 - 8:39am
tags:
Arqule, liver cancer, FDA, tivantinib
Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Friday, January 17, 2014 - 8:37am
tags:
Sanofi, LixiLan, insulin, Lantus, diabetes, Zealand Pharma, Lyxumia
Chelsea Therapeutics May Be A Revenue Generating Biotech By The End Of 2014
Seeking Alpha
Friday, January 17, 2014 - 8:36am
tags:
Chelsea Therapeutics, Northera
Google develops contact lens glucose monitor; could end finger pricks for diabetics
Yahoo/AP
Friday, January 17, 2014 - 8:28am
tags:
Google, diabetes, blood glucose monitoring, glucose monitors, devices, Google X
FDA advisory panel rejects J&J drug for acute coronary syndrome
Reuters
Thursday, January 16, 2014 - 4:54pm
tags:
JNJ, acute coronary syndrome, Xarelto, advisory panels, FDA
Novartis may finally face generic competition for Diovan
Fierce Pharma
Thursday, January 16, 2014 - 4:53pm
tags:
Diovan, Novartis, generics, Ranbaxy, hypertension
Boston Scientific Says It Will Pause Hypertension Trial
Bloomberg
Thursday, January 16, 2014 - 4:49pm
tags:
Boston Scientific, hypertension, Vessix, Medtronic, devices
Solid 2014 Expected for Shire
Yahoo/Zacks.com
Thursday, January 16, 2014 - 4:48pm
tags:
Shire
[video] Biotech: 2014's favored child
CNBC
Thursday, January 16, 2014 - 4:47pm
tags:
biotech
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
Thursday, January 16, 2014 - 11:44am
tags:
earnings, Forest Labs, JNJ, Ironwood
Foundation Medicine: A Unique Cancer Play Backed By Google Ventures
Wall St Cheat Sheet
Thursday, January 16, 2014 - 11:39am
tags:
Foundation Medicine, Google, cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.